The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation.
Open accessAbstract
One approach to gene therapy for hepatic diseases is to remove hepatocytes from an affected individual, genetically alter them in vitro, and reimplant them into a receptive locus. Although returning hepatocytes to the liver itself would be advantageous, the feasibility of this approach has never been evaluated due to the inability to distinguish donor from host hepatocytes. To unambiguously identify transplanted hepatocytes after transplantation, and to better quantitate their number and degree of liver function, two transgenic mouse lines were generated in a C57BL/6 background. The first expresses the Escherichia coli beta-galactosidase gene from the relatively liver-specific human alpha 1-antitrypsin (hAAT) promoter and allows transgenic hepatocytes to be readily identified after 5-bromo-4-chloro-3-indolyl beta-D-galactoside staining; the second produces the hAAT protein under control of the same promoter, which enables hepatocyte survival and maintenance of liver function to be quantitated by measuring the serum levels of hAAT. Hepatocytes isolated from transgenic donors were transplanted into nontransgenic C57BL/6 recipients by intrasplenic injection. Surprisingly, a large fraction of these cells were identified within the liver parenchyma but not the spleen at 2 months after transplantation. The high levels of serum hAAT detected in transplant recipients were stable for greater than 6 months, suggesting that established cells will survive indefinitely. These results have important implications for liver organogenesis and hepatic gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS
Berry, M. N., & Friend, D. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.43.3.506 · Cited by 4,424
Hepatocellular Transplantation for Metabolic Deficiencies: Decrease of Plasma Bilirubin in Gunn Rats
Matas, A. J., Sutherland, D. E. R., Steffes, M. W., Mauer, S. M., Sowe, A., Simmons, R. L., & Najarian, J. S. (1976) · Science · doi:10.1126/science.818706 · Cited by 294
MacGregor, G. R., Mogg, A. E., Burke, J. F., & Caskey, C. T. (1987) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01535207 · Cited by 225
Survival, organization, and function of microcarrier-attached hepatocytes transplanted in rats.
Demetriou, A. A., Levenson, S. Μ., Novikoff, P. M., Novikoff, A. B., Chowdhury, N. R., Whiting, J., Reisner, A., & Chowdhury, J. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7475 · Cited by 151
Self-citationRetrovirus-mediated transduction of adult hepatocytes.
Wilson, J. M., Jefferson, D. M., Chowdhury, J. R., Novikoff, P. M., Johnston, D. E., & Mulligan, R. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3014 · Cited by 136
Self-citationModulation of the liver specific phenotype in the human hepatoblastoma line Hep G2
Kelly, J. H., & Darlington, G. (1989) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02626182 · Cited by 134
Self-citationCg, G., Arborgh, B., Björkén, C., Sundberg, B., & Lundgren, G. (1977) · PubMed · Cited by 128
Expression of retrovirally transduced genes in primary cultures of adult rat hepatocytes.
Wolff, J. A., Yee, J. K., Skelly, H., Moores, J. C., Respess, J. G., Friedmann, T., & Leffert, H. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3344 · Cited by 84
Gupta, S. K., Chowdhury, N. R., Jagtiani, R. K., Gustin, K. E., Aragona, E., Shafritz, D. A., Chowdhury, J. R., & Burk, R. D. (1990) · Transplantation · doi:10.1097/00007890-199009000-00022 · Cited by 62
Self-citationProspects for hepatocyte transplantation
Bumgardner, G. L., Fasola, C. G., & Sutherland, D. E. R. (1988) · Hepatology · doi:10.1002/hep.1840080533 · Cited by 45
Cited by
Development of nanocomposites for bone grafting
MURUGAN, R., & RAMAKRISHNA, S. (2005) · Composites Science and Technology · doi:10.1016/j.compscitech.2005.07.022 · Cited by 742
Replacement of Diseased Mouse Liver by Hepatic Cell Transplantation
Rhim, J. A., Sandgren, E. P., Degen, J. L., Palmiter, R. D., & Brinster, R. L. (1994) · Science · doi:10.1126/science.8108734 · Cited by 577
Chapter 8 Use of Recombinant Adenovirus for Metabolic Engineering of Mammalian Cells
Becker, T. C., Noel, R. J., Coats, W. S., Gómez-Foix, A. M., Alam, T., Gerard, R. D., & Newgard, C. B. (1994) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)60603-2 · Cited by 569
Overturf, K., Al-Dhalimy, M., Tanguay, R., Brantly, M., Ou, C.-N., Finegold, M., & Grompe, M. (1996) · Nature Genetics · doi:10.1038/ng0396-266 · Cited by 549
Self-citationAdenovirus–mediated in vivo gene transfer and expression in normal rat liver
Jaffe, H. A., Danel, C., Longenecker, G., Metzger, M., Setoguchi, Y., Rosenfeld, M. A., Gant, T. W., Thorgeirsson, S. S., Stratford-Perricaudet, L. D., Perricaudet, M., et al. (1992) · Nature Genetics · doi:10.1038/ng0892-372 · Cited by 449
Human Hepatocyte Transplantation: Worldwide Results
Fisher, R. A., & Strom, S. C. (2006) · Transplantation · doi:10.1097/01.tp.0000231689.44266.ac · Cited by 445
Design Strategies of Tissue Engineering Scaffolds with Controlled Fiber Orientation
Murugan, R., & Ramakrishna, S. (2007) · Tissue Engineering · doi:10.1089/ten.2006.0078 · Cited by 415
In vivo detection of single cells by MRI
Shapiro, E. M., Sharer, K., Skrtic, S., & Koretsky, A. P. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20718 · Cited by 378
Biomaterials for tissue engineering
Kim, B.-S., Baez, C. E., & Atala, A. (2000) · World Journal of Urology · doi:10.1007/s003450050002 · Cited by 374
Hepatocyte Transplantation for the Treatment of Human Disease
Strom, S., Chowdhury, J., & Fox, I. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007096 · Cited by 366
Self-citationHuman hepatocyte transplantation: current experience and future challenges
Dhawan, A., Puppi, J., Hughes, R. D., & Mitry, R. R. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.44 · Cited by 362
Isolation of hepatoblasts based on the expression of Dlk/Pref-1
Tanimizu, N., Nishikawa, M., Saito, H., Tsujimura, T., & Miyajima, A. (2003) · Journal of Cell Science · doi:10.1242/jcs.00388 · Cited by 334
Cell therapy for liver disease: From liver transplantation to cell factory
Forbes, S. J., Gupta, S., & Dhawan, A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.040 · Cited by 325
Self-citationCell and tissue engineering for liver disease
Bhatia, S. N., Underhill, G. H., Zaret, K. S., & Fox, I. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3005975 · Cited by 309
Assessment of Recombinant Adenoviral Vectors for Hepatic Gene Therapy
Li, Q., Kay, M. A., Finegold, M., Stratford-Perricaudet, L. D., & Woo, S. L. C. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.4-403 · Cited by 305
Self-citationUse of differentiated pluripotent stem cells in replacement therapy for treating disease
Fox, I. J., Daley, G. Q., Goldman, S. A., Huard, J., Kamp, T. J., & Trucco, M. (2014) · Science · doi:10.1126/science.1247391 · Cited by 291
Retroviral-mediated gene transfer into hepatocytes in vivo.
Ferry, N., Duplessis, O., Houssin, D., Danos, O., & Heard, J. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8377 · Cited by 285
Gupta, S., Rajvanshi, P., Sokhi, R., Slehria, S., Yam, A., Kerr, A., & Novikoff, P. M. (1999) · Hepatology · doi:10.1002/hep.510290213 · Cited by 282
Self-citationSystemic Delivery of Recombinant Proteins by Genetically Modified Myoblasts
Barr, E., & Leiden, J. M. (1991) · Science · doi:10.1126/science.1962212 · Cited by 281
Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administration
Kay, M. A., Holterman, A.-X., Meuse, L., Gown, A., Ochs, H. D., Linsley, P. S., & Wilson, C. B. (1995) · Nature Genetics · doi:10.1038/ng1095-191 · Cited by 280
Nf2 /Merlin controls progenitor homeostasis and tumorigenesis in the liver
Benhamouche, S., Curto, M., Saotome, I., Gladden, A. B., Liu, C.-H., Giovannini, M., & McClatchey, A. I. (2010) · Genes & Development · doi:10.1101/gad.1938710 · Cited by 269
Cell therapy for advanced liver diseases: repair or rebuild
Dwyer, B. J., Macmillan, M. T., Brennan, P. N., & Forbes, S. J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.09.014 · Cited by 141
Horslen, S. P., & Fox, I. J. (2004) · Transplantation · doi:10.1097/01.tp.0000113809.53415.c2 · Cited by 119
Bell, J. B., Aronovich, E. L., Schreifels, J. M., Beadnell, T. C., & Hackett, P. B. (2010) · Molecular Therapy · doi:10.1038/mt.2010.152 · Cited by 45
Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death–Ligand 1
Li, Y., Lu, L., Qian, S., Fung, J. J., & Lin, F. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501737 · Cited by 29
“Although direct intrasplenic injection was used to deliver cells, including hepatocytes (46) and tumor cells (47), into the spleen in experimental studies, this approach was not useful for our purposes,”
Method
Metadata
- Authors
- Ponder, K. P., Gupta, S., Leland, F., Darlington, G., Finegold, M., DeMayo, J., Ledley, F. D., Chowdhury, J. R., & Woo, S. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1991-02-15
- Volume
- 88
- Issue
- 4
- Pages
- 1217-1221
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2089582480
- Cited by
- 369
- References
- 12
- FWCI
- 14.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.